Stay updated with breaking news from Eric Elenko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its price target lifted by Mizuho from $270.00 to $274.00 in a research note published on Monday morning, The Fly reports. A number of other equities analysts also recently commented on KRTX. Wedbush restated an outperform rating on shares of Karuna Therapeutics in a report on Tuesday, March […]
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its price objective lifted by investment analysts at Mizuho from $270.00 to $274.00 in a research report issued to clients and investors on Monday, The Fly reports. Mizuho’s target price points to a potential upside of 25.68% from the company’s current price. A number of other research firms […]
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) announced its quarterly earnings results on Thursday. The company reported ($2.80) EPS for the quarter, topping analysts’ consensus estimates of ($2.86) by $0.06, Briefing.com reports. Karuna Therapeutics had a negative return on equity of 34.88% and a negative net margin of 2,795.96%. The company had revenue of $0.65 million […]
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) is scheduled to be releasing its earnings data before the market opens on Thursday, May 4th. Analysts expect Karuna Therapeutics to post earnings of ($2.86) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Karuna Therapeutics […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) has been assigned an average rating of “Moderate Buy” from the sixteen ratings firms that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average twelve-month target price […]